|
Laboratory
Findings |
4 April 2024 | 10 April 2024 | 19 April 2024 | 26 April 2024 | 1 May 2024 | 24 June 2024–28 June 2024 |
Reference
Interval |
|
Start of Antibiotic Therapy
(First Hospital Stay) |
Identification of Toxocariasis and
Implementation of Appropriate Treatment (Second Hospital Stay) |
Control of Treatment
(Third Hospital Stay) |
|||||
| Blood morphology | |||||||
| Leukocytes | 10.2 | 7.5 | 8.8 | - | 6.8 | 10.1 | 3.8–10 K/uL |
| Erythrocytes | 5.3 | 5.44 | 5.55 | - | 5.4 | 5.09 | 3.7–5.1 mln/uL |
| Hemoglobin | 15.6 | 15.8 | 16.2 | - | 15.6 | 15.0 | 12–16 g/dL |
| Haematocrit | 43.5 | 45.3 | 44.9 | - | 44.4 | 43.7 | 37–47% |
| Blood platelets | 225 | 278 | 264 | - | 258 | 233 | 140–440 K/mL |
| Neutrophils | - | 3.70 | 4.70 | - | - | 7.33 | 2.5–7 K/uL |
| Lymphocytes | - | 1.77 | 1.6 | - | - | 1.93 | 1–3.5 K/uL |
| Monocytes | - | 0.83 | 0.87 | - | - | 0.76 | 0.2–1 K/uL |
| Eosinophils | - | 1.15 | 1.58 | - | - | 0.06 | 0.1–0.5 K/uL |
| Basophiles | - | 0.0 | 0.0 | - | - | 0.0 | 0–0.1 K/uL |
| Neutrophils | - | 49.4 | 53.6 | - | - | 72.3 | 40–70% |
| Lymphocytes | - | 23.7 | 18.2 | - | - | 19.1 | 20–45% |
| Monocytes | - | 11.1 | 9.9 | - | - | 7.5 | 2–10% |
| Eosinophils | - | 15.4 | 18.0 | - | - | 0.6 | 1–5% |
| Basophiles | - | 0.4 | 0.3 | - | - | 0.5 | 0–2% |
| Biochemistry | |||||||
| Toxocara canis IgG | - | - | - | 16 . 83 | - | 9.1 | >9 NTU—negative 9–11 inconclusive <11 positive |
| LDH | - | - | 228 | - | - | - | 225–450 U/L |
| Total protein | - | - | 7.1 | - | - | - | 6.4–8.3 g/dL |
| Total bilirubin | 0.75 | - | 0.66 | - | - | 1.22 | 0–0.9 mg/dL |
| Glucose | 96 | - | 95 | - | - | 93 | 70–99 mg/dL |
| GGTP | - | - | 9 | - | - | 6–42 U/L | |
| Urea | - | - | 46.3 | - | 33.4 | 38.6 | 16.6–48.5 mg/dL |
| Sodium | 136 | - | 140 | - | 141 | 138 | 136–145 mmol/L |
| Potassium | 3.52 | - | 3.47 | - | 4.05 | 3.69 | 3.5–5.1 mmol/L |
| Magnesium | 0.91 | - | - | - | - | - | 0.66–1.07 mmol/L |
| ALT | 11 | - | 12 | - | - | 140 | 0–33 U/L |
| AST | 17 | - | 17 | - | - | 86 | 0–32 U/L |
| CK-MB | - | - | - | - | - | 10.2 | 0–25 U/L |
| Troponin I | <0.100 | - | - | - | - | <0.100 | 0–0.3 ng/mL |
| NT-proBNP | 33.44 | - | 21.99 | - | - | - | 0–125 pg/mL |
| Creatinine | 0.87 | - | 1.06 | - | 1.13 | 0.98 | 0.5–0.9 mg/dL |
| eGFR | 80.0 | 63.7 | - | 59.2 | 69.7 | <90 mL/min/1.73 m2—normal 60–89—mildly reduced 30–59 moderately reduced 15–29 severely reduced >15 renal failure |
|
| Immunochemistry | |||||||
| CRP | 39.45 | 14.13 | 25.18 | - | 5.12 | 4.63 | 0–5 mg/L |
| Total IgE | - | - | 111.0 | - | - | 9.7 | 0–100 IU/mL |
| Hormones | |||||||
| TSH | 2.120 | - | 2.270 | - | - | 0.720 | 0.27–4.2 uIU/mL (non-pregnant women) |
| ft3 | 3.07 | - | - | - | - | - | 2.04–4.04 ng/dL (non-pregnant women) |
| ft4 | 1.28 | - | - | - | - | - | 0.93–1.7 ng/dL (non-pregnant women) |
| Arterial Blood Gas | |||||||
| pH | 7.44 | - | 7.48 | - | - | 7.42 | 7.35–7.45 |
| pCO2 | 25.4 | - | 34.00 | - | - | 32.5 | 35–45 mmHg |
| pO2 | 68.6 | - | 62.00 | - | - | 60.3 | 80–100 mmHg |
| Saturation | 94.7 | - | 93.40 | - | - | 91.8 | 90–96% |
| HCO3 | 17.00 | - | 24.50 | - | - | 20.5 | 20–26 mmol/L |
| BE | −5.20 | - | 1.50 | - | - | −3.00 | −2.5–5.5 mmol/L |
| Coaguology | |||||||
| D-dimers | 1.56 | - | - | - | - | 0.41 | 0–0.5 ug/mL |
| INR | 0.99 | - | 1.16 | - | - | 1.09 | 0.8–1.2 |
| Prothrombin index | 101 | - | 87 | - | - | 92 | 80–120% |
| Prothrombin time | 10.5 | - | 12.2 | - | - | 11.3 | 8–12 s |
| increased parameter, decreased parameter. | |||||||